High Caesarean section rate has been described as a pandemic, and one of its most serious consequences is Placenta Accreta spectrum (PAS). Since January 2020, entire world is facing the SARS-CoV2 pandemic; under these circumstances, PAS patients care faces additional challenges. We describe our experience managing PAS patients who required surgery during SARS-CoV2 infection. Descriptive, retrospective study. Clinical results of patients with SARS-CoV2 infection during PAS surgery, in two reference hospitals, were analysed. Some practical recommendations are discussed. COVID pandemic imposes additional challenges to PAS treatment, that must be considered by the “PAS teams”: The median operative time is longer. COVID pandemic has caused a global shortage of blood components. A higher incidence of thrombosis has been reported, which suggests the need for early postoperative thromboprophylaxis. Some hospitals include in their PAS protocols the transfer between different rooms during the surgical management. It may be necessary to rethink the “treatment protocol” for PAS. An increased risk of contagion during orotracheal intubation has been described. It would seem logical to favour conductive anesthesia. Postoperative mortality is increased during the following 7 weeks after the SARS-CoV2 infection, being increasingly lower as the surgery moves away from the infection date. PAS patients undergoing surgery during SARS-CoV2 infection face additional challenges, PAS teams must be prepared.